First robotic cardiac surgery in Americas performed with SSi Mantra

GUAYAQUIL, Ecuador - SS Innovations International, Inc. (Nasdaq: SSII), a $685 million market cap medical technology company with impressive revenue growth of 177% over the last twelve months, announced that the first robotic cardiac surgery in the Americas has been completed using its SSi Mantra 3 surgical robotic system.

On June 8, Dr. Juan Zuniga of Interhospital in Guayaquil performed an Atrial Septal Defect closure, a procedure that repairs a hole between the upper chambers of the heart.

"The equipment was very easy to handle and manipulate, and the results were effective," Dr. Zuniga said following the surgery. "We were very happy with the results in achieving a successful closure and the patient is recovering very well."

According to Dr. Zuniga, the minimally invasive procedure offers advantages including faster recovery, reduced bleeding, and more precise tissue manipulation and suturing.

Interhospital, which became the first South American hospital to install the SSi Mantra system, has used the technology for various complex surgical procedures since installation.

The SSi Mantra surgical robotic system features 3 to 5 modular robotic arms, a 3D 4K monitor, and utilizes over 40 different types of robotic endo-surgical instruments to support various specialties including cardiac surgery.

SS Innovations International develops surgical robotic technologies aimed at making robotic surgery more affordable and accessible. The company is headquartered in India with operations in the United States.

This information is based on a press release issued by SS Innovations.

In other recent news, SS Innovations International, Inc. has announced several key developments. The company plans to submit a De Novo Classification Request to the U.S. Food and Drug Administration in July 2025 for its SSi Mantra 3 surgical robotic system. This move aims to secure authorization to market the system in the United States. Additionally, SS Innovations has appointed Dr. Vishwajyoti P. Srivastava as the new Chief Executive Officer for the Asia Pacific region, effective May 21, 2025. This appointment is part of the company’s strategy to strengthen its leadership and expand its presence in the Asia Pacific market.

The company has also named Arvind Palaniappan as Interim Chief Financial Officer following the planned departure of Anup Sethi. Palaniappan brings over 30 years of financial and operations management experience to the role. Furthermore, SS Innovations has been actively working on expanding the global reach of its SSi Mantra surgical robotic systems, which have been installed in 75 hospitals worldwide. The company also seeks European Union CE Mark approval for its robotic systems. These recent developments highlight SS Innovations’ ongoing efforts to enhance its leadership team and expand its market presence.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.